USA - NYSE:CTEV - US62548M2098 - Common Stock
Taking everything into account, CTEV scores 2 out of 10 in our fundamental rating. CTEV was compared to 35 industry peers in the Health Care Technology industry. CTEV has a bad profitability rating. Also its financial health evaluation is rather negative. CTEV does not seem to be growing, but still is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.08% | ||
| ROE | N/A | ||
| ROIC | 1.03% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.72% | ||
| PM (TTM) | N/A | ||
| GM | 74.43% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.27 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.98 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 11.39 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:CTEV (10/27/2025, 9:36:25 AM)
70.385
+0.7 (+1%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.24 | ||
| P/FCF | N/A | ||
| P/OCF | 16.42 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.39 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.08% | ||
| ROE | N/A | ||
| ROCE | 1.3% | ||
| ROIC | 1.03% | ||
| ROICexc | 1.04% | ||
| ROICexgc | 16.29% | ||
| OM | 6.72% | ||
| PM (TTM) | N/A | ||
| GM | 74.43% | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.19 | ||
| Cap/Depr | 28.61% | ||
| Cap/Sales | 13.43% | ||
| Interest Coverage | 0.23 | ||
| Cash Conversion | 14.07% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | -0.27 |
ChartMill assigns a fundamental rating of 2 / 10 to CTEV.
ChartMill assigns a valuation rating of 1 / 10 to CLARITEV CORP (CTEV). This can be considered as Overvalued.
CLARITEV CORP (CTEV) has a profitability rating of 3 / 10.
The Earnings per Share (EPS) of CLARITEV CORP (CTEV) is expected to grow by 76.94% in the next year.